The adult with a Fontan: A panacea without a cure?

Circulation Journal

Volumn 77, Issue 11, 2013, Pages 2672-2681

  Lastinger, Lauren ^a   Zaidi, Ali N ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Congenital heart disease; Fontan procedure; Heart defects

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HEPARIN; LOOP DIURETIC AGENT; MILRINONE; NESIRITIDE; SILDENAFIL; WARFARIN;

BRONCHITIS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CORONARY HEMODYNAMICS; DISEASE ASSOCIATION; EXERCISE; FONTAN PROCEDURE; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEART RHYTHM; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FUNCTION; HUMAN; HYPOXEMIA; INTRAOPERATIVE AWARENESS; LIVER DISEASE; LUNG VASCULAR RESISTANCE; PREGNANCY; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; THROMBOEMBOLISM; TREATMENT FAILURE;

ADULT; FONTAN PROCEDURE; HEART RATE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; POSTOPERATIVE COMPLICATIONS; VENTRICULAR FUNCTION;

EID: 84886452981     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1105     Document Type: Review

References (98)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240-248.
2. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 85-92.
3. Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: Early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol 2001; 37: 933-939.
4. Kreutzer G, Galíndez E, Bono H, De Palma C, Laura JP. An operation for correction of tricuspid atresia. J Thorac Cardiovasc Surg 1973; 66: 613-621.
5. Kanakis MA, Petropoulos AC, Mitropoulos FA. Fontan operation. Hellenic J Cardiol 2009; 50: 133-141.
6. Gewillig M. The Fontan circulation. Heart 2005; 91: 839-846.
7. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations: Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96: 682-695.
8. Marcelletti C, Corno A, Giannico S, Marino B. Inferior vena cavapulmonary artery extracardiac conduit: A new form of right heart bypass. J Thorac Cardiovasc Surg 1990; 100: 228-232.
9. Khairy P, Poirier N. Is the extracardiac conduit the preferred Fontan approach for patients with univentricular hearts? The extracardiac conduit is not the preferred Fontan approach for patients with univentricular hearts. Circulation 2012; 126: 2516-2525, discussion 2525.
10. Gewillig MH, Lundström UR, Deanfield JE, Bull C, Franklin RC, Graham TP Jr, et al. Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. Circulation 1990; 81: 118-127.
11. Gewillig M. Ventricular dysfunction of the functionally univentricular heart: Management and outcomes. Cardiol Young 2005; 15(Suppl 3): 31-34.
12. West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung: Relation to vascular and alveolar pressures. J Appl Physiol 1964; 19: 713-724.
13. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Sasaki N, Asano H, et al. Ventricular afterload and ventricular work in Fontan circulation: Comparison with normal two-ventricle circulation and singleventricle circulation with Blalock-Taussig shunts. Circulation 2002; 105: 2885-2892.
14. Szabo G, Buhmann V, Graf A, Melnitchuk S, Hagl S, Vahl CF. Perfusion- contractility matching during Fontan circulation. Biomed Tech (Berl) 2002; 47(Suppl 1): 912-914.
15. Nakamura Y, Yagihara T, Kagisaki K, Hagino I, Kobayashi J. Ventricular performance in long-term survivors after Fontan operation. Ann Thorac Surg 2011; 91: 172-180.
16. Cheung YF, Penny DJ, Redington AN. Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 2000. 83: 420-424.
17. d'Udekem Y, Cheung MM, Setyapranata S, Iyengar AJ, Kelly P, Buckland N, et al. How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias. Ann Thorac Surg 2009. 88: 1961-1969.
18. Saliba Z, Butera G, Bonnet D, Bonhoeffer P, Villain E, Kachaner J, et al. Quality of life and perceived health status in surviving adults with univentricular heart. Heart 2001; 86: 69-73.
19. Paridon SM, Mitchell PD, Colan SD, Williams RV, Blaufox A, Li JS, et al. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 2008; 52: 99-107.
20. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, et al. Contemporary outcomes after the Fontan procedure: A Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008; 52: 85-98.
21. Anderson PA, Breitbart RE, McCrindle BW, Sleeper LA, Atz AM, Hsu DT, et al. The Fontan patient: Inconsistencies in medication therapy across seven Pediatric Heart Network centers. Pediatr Cardiol 2010; 31: 1219-1228.
22. Blaufox AD, Sleeper LA, Bradley DJ, Breitbart RE, Hordof A, Kanter RJ, et al. Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age. J Thorac Cardiovasc Surg 2008; 136: 100-107.
23. Fredenburg TB, Johnson TR, Cohen MD. The Fontan procedure: Anatomy, complications, and manifestations of failure. Radiographics 2011; 31: 453-463.
24. Beghetti M. Fontan and the pulmonary circulation: A potential role for new pulmonary hypertension therapies. Heart 2010; 96: 911-916.
25. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, et al. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: A randomized, double-blind, placebo-controlled, crossover trial. Circulation 2011; 123: 1185-1193.
26. Rhodes J, Ubeda-Tikkanen A, Clair M, Fernandes SM, Graham DA, Milliren CE, et al. Effect of inhaled iloprost on the exercise function of Fontan patients: A demonstration of concept. Int J Cardiol 2013 March 29, doi:10.1016/j.ijcard.2013.03.014 [E-pub ahead of print].
27. Collins KK. The spectrum of long-term electrophysiologic abnormalities in patients with univentricular hearts. Congenit Heart Dis 2009; 4: 310-317.
28. d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, et al. The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 2007; 116(Suppl): I157-I164.
29. Nürnberg JH, Ovroutski S, Alexi-Meskishvili V, Ewert P, Hetzer R, Lange PE. New onset arrhythmias after the extracardiac conduit Fontan operation compared with the intraatrial lateral tunnel procedure: Early and midterm results. Ann Thorac Surg 2004; 78: 1979-1988, discussion 1988.
30. Ovroutski S, Dähnert I, Alexi-Meskishvili V, Nürnberg JH, Hetzer R, Lange PE. Preliminary analysis of arrhythmias after the Fontan operation with extracardiac conduit compared with intra-atrial lateral tunnel. Thorac Cardiovasc Surg 2001; 49: 334-337.
31. Gandhi SK, Bromberg BI, Rodefeld MD, Schuessler RB, Boineau JP, Cox JL, et al. Lateral tunnel suture line variation reduces atrial flutter after the modified Fontan operation. Ann Thorac Surg 1996; 61: 1299-1309.
32. Shirai LK, Rosenthal DN, Reitz BA, Robbins RC, Dubin AM. Arrhythmias and thromboembolic complications after the extracardiac Fontan operation. J Thorac Cardiovasc Surg 1998; 115: 499-505.
33. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation 2007; 115: 800-812.
34. Stephenson EA, Lu M, Berul CI, Etheridge SP, Idriss SF, Margossian R, et al. Arrhythmias in a contemporary fontan cohort: Prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol 2010; 56: 890-896.
35. Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart 2012; 98: 1098-1104.
36. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol 2007; 28: 448-456.
37. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008; 118: 2395-2451.
38. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002; 5: 36-47.
39. Jacobs ML, Pourmoghadam KK. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 2007; 28: 457-464.
40. Tomita H, Yamada O, Ohuchi H, Ono Y, Arakaki Y, Yagihara T, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 2001; 11: 62-66.
41. Ravn HB, Hjortfal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001; 85: 61-65.
42. Grewal J, Al Hussein M, Feldstein J, Kiess M, Ellis J, Human D, et al. Evaluation of silent thrombus after the Fontan operation. Congenit Heart Dis 2013; 8: 40-47.
43. Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, et al. A multicenter, randomized trial comparing heparin/ warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 2011; 58: 645-651.
44. Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl): e737S-e801S, doi:10.1378/ chest.11-2308.
45. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348-1352.
46. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93: 579-584.
47. Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE Jr, Earing MG. Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011; 6: 190-201.
48. Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart 2013; 99: 491-496.
49. Schwartz MC, Sullivan L, Cohen MS, Russo P, John AS, Guo R, et al. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: An autopsy study. J Thorac Cardiovasc Surg 2012; 143: 904-909.
50. Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, et al. Congenital heart disease and the liver. Hepatology 2012; 56: 1160-1169.
51. Ginde S, Hohenwalter MD, Foley WD, Sowinski J, Bartz PJ, Venkatapuram S, et al. Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis 2012; 7: 235-242.
52. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Proteinlosing enteropathy after the Fontan operation: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998; 115: 1063-1073.
53. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007; 2: 288-300.
54. Cohen MI, Rhodes LA, Wernovsky G, Gaynor JW, Spray TL, Rychik J. Atrial pacing: An alternative treatment for protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 2001; 121: 582-583.
55. Ryerson L, Goldberg C, Rosenthal A, Armstrong A. Usefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliation. Am J Cardiol 2008; 101: 248-251.
56. Turner Z, Lanford L, Webber S. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation. Congenit Heart Dis 2012; 7: 24-30.
57. John AS, Driscoll DJ, Warnes CA, Phillips SD, Cetta F. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2011; 92: 1451-1456.
58. Brancaccio G, Carotti A, D'Argenio P, Michielon G, Parisi F. Protein- losing enteropathy after Fontan surgery: Resolution after cardiac transplantation. J Heart Lung Transplant 2003; 22: 484-486.
59. Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for "failed" Fontan: A singleinstitution experience. J Thorac Cardiovasc Surg 2012; 143: 1183-1192.e4, doi:10.1016/j.jtcvs.2011.12.039.
60. McGuirk SP, Winlaw DS, Langley SM, Stumper OF, de Giovanni JV, Wright JG, et al. The impact of ventricular morphology on midterm outcome following completion total cavopulmonary connection. Eur J Cardiothorac Surg 2003; 24: 37-46.
61. Hirsch JC, Goldberg C, Bove EL, Salehian S, Lee T, Ohye RG, et al. Fontan operation in the current era: A 15-year single institution experience. Ann Surg 2008; 248: 402-410.
62. Khambadkone S. The Fontan pathway: What's down the road? Ann Pediatr Cardiol 2008; 1: 83-92.
63. Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther 2008; 6: 165-174.
64. Kukin ML. beta-blockers in chronic heart failure: Considerations for selecting an agent. Mayo Clin Proc 2002; 77: 1199-1206.
65. Ishibashi N, Park IS, Takahashi Y, Nishiyama M, Murakami Y, Mori K, et al. Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation. Pediatr Cardiol 2006; 27: 473-475.
66. Ishibashi N, Park IS, Waragai T, Yoshikawa T, Murakami Y, Mori K, et al. Effect of carvedilol on heart failure in patients with a functionally univentricular heart. Circ J 2011; 75: 1394-1399.
67. Hjortdal VE, Stenbøg EV, Ravn HB, Emmertsen K, Jensen KT, Pedersen EB, et al. Neurohormonal activation late after cavopulmo- nary connection. Heart 2000; 83: 439-443.
68. Hensen J, Abraham WT, Dürr JA, Schrier RW. Aldosterone in congestive-heart-failure: Analysis of determinants and role in sodium retention. Am J Nephrol 1991; 11: 441-446.
69. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002.
70. Cesario D, Clark J, Maisel A. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study. Am Heart J 1998; 135: 121-129.
71. Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, et al. Assessment of dyspnea in acute decompensated heart failure: Insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol 2012; 59: 1441-1448.
72. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
73. Abraham WT. Cardiac resynchronization therapy for heart failure: Biventricular pacing and beyond. Curr Opin Cardiol 2002; 17: 346-352.
74. Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J 2013; 34: 2592-2599.
75. Sojak V, Mazic U, Cesen M, Schrader J, Danojevic N. Cardiac resynchronization therapy for the failing Fontan patient. Ann Thorac Surg 2008; 85: 2136-2138.
76. Magee AG, McCrindle BW, Mawson J, Benson LN, Williams WG, Freedom RM. Systemic venous collateral development after the bidirectional cavopulmonary anastomosis: Prevalence and predictors. J Am Coll Cardiol 1998; 32: 502-508.
77. Ghanayem NS, Berger S, Tweddell JS. Medical management of the failing Fontan. Pediatr Cardiol 2007; 28: 465-471.
78. Seear M, Hui H, Magee F, Bohn D, Cutz E. Bronchial casts in children: A proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med 1997; 155: 364-370.
79. Grutter G, Di Carlo D, Gandolfo F, Adorisio R, Alfieri S, Michielon G, et al. Plastic bronchitis after extracardiac Fontan operation. Ann Thorac Surg 2012; 94: 860-864.
80. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92: 1290-1294.
81. Harris IS. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis 2011; 53: 305-311.
82. Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P, Mitchell ME, et al. Fontan palliation in the modern era: Factors impacting mortality and morbidity. Ann Thorac Surg 2009; 88: 1291-1299.
83. Mavroudis C, Deal BJ, Backer CL. Arrhythmia surgery in association with complex congenital heart repairs excluding patients with fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003; 6: 33-50.
84. Deal BJ, Mavroudis C, Backer CL, Buck SH, Johnsrude C. Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation 2002; 106: 575-579.
85. Weinstein S, Chan D. Extracardiac Fontan conversion, cryoablation, and pacemaker placement for patients with a failed Fontan. Semin Thorac Cardiovasc Surg 2005; 17: 170-178.
86. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001; 122: 863-871.
87. Backer CL, Deal BJ, Mavroudis C, Franklin WH, Stewart RD. Conversion of the failed Fontan circulation. Cardiol Young 2006; 16(Suppl 1): 85-91.
88. Michielon G, Carotti A, Pongiglione G, Cogo P, Parisi F. Orthotopic heart transplantation in patients with univentricular physiology. Curr Cardiol Rev 2011; 7: 85-91.
89. Kanter KR, Mahle WT, Vincent RN, Berg AM, Kogon BE, Kirshbom PM. Heart transplantation in children with a Fontan procedure. Ann Thorac Surg 2011; 91: 823-829, discussion 829-830.
90. Bernstein D, Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, et al. Outcome of listing for cardiac transplantation for failed Fontan: A multi-institutional study. Circulation 2006. 114: 273-280.
91. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009; 54: 160-165.
92. Gamba A, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg 2004; 127: 555-562.
93. Bhama JK, Shulman J, Bermudez CA, Bansal A, Ramani R, Teuteberg JJ, et al. Heart transplantation for adults with congenital heart disease: Results in the modern era. J Heart Lung Transplant 2013; 32: 499-504.
94. Kovach JR, Naftel DC, Pearce FB, Tresler MA, Edens RE, Shuhaiber JH, et al. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: An analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant 2012; 31: 133-139.
95. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, et al. Evaluating failing Fontans for heart transplantation: Predictors of death. Ann Thorac Surg 2009; 88: 558-563, discussion 563-564.
96. Vanderpluym C, Urschel S, Buchholz H. Advanced therapies for congenital heart disease: Ventricular assist devices and heart transplantation. Can J Cardiol 2013; 29: 796-802.
97. Le Gloan L, Mercier LA, Dore A, Marcotte F, Ibrahim R, Mongeon FP, et al. Recent advances in adult congenital heart disease. Circ J 2011; 75: 2287-2295.
98. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA; Pediatric Heart Transplant Study Investigators. Outcomes of children bridged to heart transplantation with ventricular assist devices: A multi-institutional study. Circulation 2006; 113: 2313-2319.